Prof. Dr. Rainer Fietkau

Medizinische Fakultät Lehrstuhl für Strahlentherapie

The inhibition of the MRN complex by Mirin radiosensitizes particularly HPV-negative HNSCC cell lines (2026) Hildebrand L, Mehravani BP, Khalifa M, Schiller P, Langkrär J, Jost T, Fietkau R, Distel L Journal article Breast cancer risk genes affecting individual radiosensitivity (2026) Vogel R, Amann N, Zuhair Kassem T, Gaß P, Mayo T, Woltereck F, Hack C, et al. Journal article How reliable is deep inspiration breath hold at CT simulation? Clinical impact of surface-guided breathing training in breast cancer radiotherapy (2026) Dietrich L, Lackner N, Karius A, Brand J, Cerqueira Lobão R, Huseynli A, Ott O, et al. Journal article ATR inhibition in combination with hypofractionated radiotherapy is superior to ATM inhibition with regard to ex vivo CD8 + T cell activation particularly for HPV-negative head and neck cancer cells (2026) Schäfer A, Zülch L, Steinsdörfer L, Donaubauer AJ, Reichardt C, Frey B, Fietkau R, et al. Journal article Phantom benchmarking for quality assurance of synthetic computed tomography in cranial magnetic resonance-only radiotherapy (2026) Axer BN, Brand J, Pieper L, Putz F, Lott J, Dickmann C, Fietkau R, et al. Journal article Prospective Phase 2 Trial: Long-term results of a salvage brachytherapy combined with interstitial hyperthermia as Re-Irradiation for locally recurrent prostate Carcinoma (2026) Strnad V, Dąbkowski M, Dąbrowski T, Brandys P, Kulik A, Gruszczyńska E, Ott O, et al. Journal article A randomized clinical study comparing trabectedin combined with regional hyperthermia with trabectedin in patients with advanced soft tissue sarcoma: HyperTET, a German Interdisciplinary Sarcoma Group trial (2026) Schuebbe GE, Xu Y, Lindner LH, Di Gioia D, Abdel-Rahman S, Kunz WG, Roshchyna T, et al. Journal article Chemoradiation of glioblastoma cells alters expression of activation and immune checkpoint molecules on type 1 and 2 dendritic cells and impacts on subsequent T cell proliferation (2026) Schuster C, Frey B, Fietkau R, Corradini S, Gaipl U, Derer A Journal article Real-world 5-year outcomes with durvalumab after chemoradiotherapy in unresectable stage III NSCLC (2026) Girard N, Bar J, Baas P, Chouaid C, Christoph DC, Field JK, Fietkau R, et al. Journal article Approaches to needle navigation in interstitial brachytherapy using infrared tracking and radiography (2026) Kreß V, Merten R, Bert C, Strnad V, Fietkau R, Corradini S, Karius A Journal article